CBDA, CBGA and Corona: What the laboratory study really shows
|
|
Time to read 1 min
Free shipping from €59 🚚
|
|
Time to read 1 min
Revised on October 9, 2026 · Hanfgeflüster Editorial Team
In 2022, a study on CBDA and CBGA made headlines. In the laboratory, it was tested whether these cannabinoid acids affect the entry of SARS-CoV-2 into cells. This does not mean that CBD products have been proven to prevent or treat COVID-19.
The research group at Oregon State University studied certain compounds from hemp and their interaction with the virus's spike protein. In the experiments described, CBDA and CBGA showed activity against the entry of the virus into human cells. This was a preclinical result under controlled conditions, not a clinical study in which people were treated with a commercially available CBD oil.
CBDA stands for cannabidiolic acid, CBGA for cannabigerolic acid. Both belong to the acidic cannabinoid forms. During processing, other cannabinoids can be produced from them. A product containing CBD therefore does not automatically contain the acids studied in a study in comparable amounts. Even the detection of a substance in the extract would not justify extrapolating the laboratory results to the finished product.
Before making a medical claim, several factors must be clarified, including the effective dose, tolerability, absorption in the body, and clinical benefit. Furthermore, virus variants and experimental conditions may differ. An interesting laboratory observation is a starting point for further research. It is not a recommendation to treat an infection yourself with cannabis compounds or to replace proven medical treatments.
Pay attention to whether a study examined cells, animals, or people. Then check which substance, formulation, and result are being referred to. Words such as prevents or helps against require clear context. Hanfgeflüster Cosmetics does not derive any promise of protection against Corona from this research. In the event of an illness, further action depends on the medical situation, not on an older blog title.
No. It examines certain cannabinoid acids in the laboratory and does not prove such an effect of a retail product.
No. They are chemically different forms.
Cosmetic CBD products are not a treatment for COVID-19.